CELUVSGTBP• 3 Months (Normalized)
CELU vs GTBP (Celularity Inc. vs GT Biopharma Inc.)
Showing Closing Date Range from Jul 7 to Oct 5, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CELU Performance $1.71
+135.21%
Celularity Inc.
Normalized Baseline0.00%
GTBP Performance $6.16
+1239.13%
GT Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
-1103.92 pts
GTBP outperforming by 1103.92 percentage points
CELUGTBP
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CELU GTBP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | CELU Price | CELU Gain (%) | GTBP Price | GTBP Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 05, 2026 | $1.71 | +135.21% | $6.16 | +1239.13% | -1103.92% |
| Oct 02, 2026 | $1.60 | +120.08% | $6.10 | +1226.09% | -1106.01% |
| Sep 29, 2026 | $- | $6.88 | +1394.57% | - | |
| Sep 28, 2026 | $1.41 | +93.95% | $6.80 | +1378.26% | -1284.31% |
| Sep 25, 2026 | $1.38 | +89.82% | $6.89 | +1397.83% | -1308.01% |
| Sep 24, 2026 | $1.32 | +81.57% | $6.83 | +1384.78% | -1303.21% |
| Sep 23, 2026 | $1.15 | +58.18% | $7.10 | +1443.48% | -1385.30% |
| Sep 22, 2026 | $1.18 | +62.31% | $- | - | |
| Sep 21, 2026 | $1.24 | +70.56% | $7.18 | +1460.87% | -1390.31% |
| Sep 18, 2026 | $1.31 | +80.19% | $7.16 | +1456.52% | -1376.33% |
| Sep 17, 2026 | $1.27 | +74.69% | $7.49 | +1528.26% | -1453.57% |
| Sep 16, 2026 | $1.29 | +77.44% | $7.81 | +1597.83% | -1520.39% |
| Sep 15, 2026 | $1.24 | +70.56% | $9.00 | +1856.52% | -1785.96% |
| Sep 14, 2026 | $1.40 | +92.57% | $11.63 | +2428.26% | -2335.69% |
| Sep 11, 2026 | $1.41 | +93.95% | $8.61 | +1771.74% | -1677.79% |
Page 1 of 5